1. We have compared the effect of central and peripheral administration of angiotensin I1 and (1-succinamoyl-5-valine-8-phenylglycine)angiotensin I1 on blood pressure of male conscious unrestrained rats with normal blood pressure, and with spontaneous hypertension or chronic renal hypertension.
Introduction
The centrally induced pressor activity of angiotensin I1 in normotensive animals is markedly attenuated by central administration of AII(') analogues with specific A11 receptor-blocking properties (Sweet, Ferrario, Khosla & Bumpus, 1973; Schoelkens, 1974 Schoelkens, , 1975 Vollmer, Buckley, Solomon & Jandhyala, 1974) . These blocking agents might act on central receptor sites of the intrinsic brain isorenin-angiotensin system (Fischer-Ferraro, Nahmod, Goldstein & Finkielman, 1971 ; Ganten, Marquez-Julio, Granger, Hayduk, Karsunky, Boucher & Genest, 1971) .
To investigate the possible participation of this intrinsic brain isorenin-angiotensin system in central blood pressure regulation in experimental hypertension, we have compared the effects of central (by injection into the lateral ventricle of the brain) and peripheral (intravenous) administration of a new specific A11 antagonist (l-succinamoyl -5 -valine -8-pheny1glycine)AII (Schoelkens, Wissmann, Lindner & Geiger, 1976), on systemic blood pressure. In addition the central pressor activity of A11 in experimental hypertension was tested. Plasma renin activity was determined after central injection of the A11 analogue in normotensive rats.
Methods
Three experimental groups were studied: (1) conscious unrestrained normotensive SpragueDawley rats (Hoe SPRK SPF71); (2) rats with spontaneous hypertension, of 10 and 14 weeks of age (FH-NIH-Montreal-Ingelheim); (3) SpragueDawley rats (Hoe SPRK SPF71) with chronic renal hypertension, induced by applying solid silver clips (0.2 mm diameter) to both renal arteries. Blood pressure was measured directly with a chronically ( I ) Abbreviation: AIl, angiotensin 11.
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implanted catheter in the abdominal aorta (Weeks & Jones, 1960) . All experiments were performed in male rats, weighing 150-400 g. The A11 antagonist ( l-succinamoyl-5-valine-8-phenylglycine)AlI (Schoelkens et al., 1976), in doses of 3 x lo-" mol/kg (30 ng/kg) and 30 x lo-" mol/kg (300 nglkg), was given centrally through a permanently implanted catheter in the lateral ventricle of the brain (Hayden, Johnson & Maickel, 1966 ) and peripherally by a permanently implanted catheter in the jugular vein of the same animal, to compare the central and the peripheral effect of the A11 analogue in the same animal. A11 was administered in the same way, in the same dose. To another group of rats A11 and the A11 analogue were dissolved in sodium chloride solution (9 g/l; saline), which was also used for control injections. The volume of injection was 5 pl. Arterial blood pressure was measured via a Statham pressure transducer (model P23Db) ; measurement and recording were done with instruments of the Hellige Program 19 (Fritz Hellige and Co., Freiburg, West Germany). Rats with a blood pressure > 150 mmHg were considered to be hypertensive.
The A11 analogue, 300 x lo-" mol/kg (3 pg/kg), was injected into the lateral ventricle of male conscious normotensive Sprague-Dawley rats (Hoe SPRK SPF71). After 5 and 15 min blood was taken for the determination of the plasma renin activity (ng of A1 h-l ml-l) by radioimmunoassay (Haber, Koerner, Page, Kliman & Purnode, 1969), a commercially available kit (Isotopendienst West, Frankfurt A.M., West Germany) being used. Results are presented as mean value ~S E M . For statistical analysis Student's 1-test was used. A P value less than 0.05 was used as the criterion of significance.
Results
Blood pressure change after administration of the A11 analogue (Fig. 1) In normotensive rats (n = 5 ) the analogue caused a small, non-significant pressure increase after either central or peripheral administration. At 5 and 15 min after central injection of the analogue in normotensive rats (n = 25) no significant changes of plasma renin activity were seen.
Spontaneously hypertensive rats (n = ll), 10 weeks old, showed a significant (P < 0.01) blood pressure decrease after central injection, but a significant (P < 0.001) increase after peripheral injection. In rats with spontaneous hypertension at an age of 14 weeks (n = 14) this centrally induced depressor response could not be observed: in these rats central injection of the analogue increased the pressure significantly (P < 0.02). A significant increase P<O.O5) was also seen after peripheral administration. Central administration of the analogue lowered the blood pressure (P<O.Ol) in all rats with chronic renal hypertension (n = 6). In contrast peripheral injection caused only a small nonsignificant increase of blood pressure.
Blood pressure change after the administration of AII
After central and peripheral administration of 2.9 x 10-mol/kg (30 ng/kg) and 29 x 10-mollkg (300 ng/kg) of A11 all rats exhibited a significant (P < 0.001) dose-related blood pressure increase.
In normotensive rats (n = 8) blood pressure was increased by 13 f 2 (SEM) mmHg and 18 f 2 mmHg respectively after central injection of the two doses, 
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and 8 f 1 mmHg and 30 f 5 mmHg respectively after peripheral injection.
The 14-weeks-old spontaneously hypertensive rats (n = 8) showed an increase of blood pressure after central application by 2 6 f 3 mmHg and 3 7 f 5 mmHg respcctively, and after peripheral application 21 f 4 mmHg and 40 f 1 1 mmHg respectively.
In rats with chronic renal hypertension (n = 10) blood pressure was elevated after central injection by 18 f4 mmHg and 28 f 3 mmHg respectively, and after peripheral injection by 21 54 mmHg and 35 f 8 mmHg respectively.
In comparison with normotensive rats, animals with spontaneous hypertension and chronic renal hypertension had a significantly increased pressor response after central administration of AII. However, no significant difference between rats with spontaneous hypertension and chronic renal hypertension was found in the pressor response.
Discussion
Animals with spontaneous hypertension and chronic renal hypertension had a significantly increased pressor response compared with the known central pressor effect of All in conscious normotensive rats (Severs & Daniels-Severs, 1973 ; Hutchinson, Schelling & Ganten, 1975; Ganten, Hutchinson & Schelling, 1975) . However, no difference in the central pressor response could be seen between the two forms of hypertension.
In contrast to normotensive rats, in which central application of the A11 analogue caused no significant pressor effect, a significant decrease of blood pressure could be demonstrated in 10-weeks-old rats with developing spontaneous hypertension. Similar results were obtained in animals with chronic renal hypertension, but not in 14-weeks-old rats with spontaneous hypertension. This suggests an A11 receptor-blocking effect at central receptor sites with a resulting blood pressure decrease in situations when an activation of the renin-angiotensin system may occur, for instance, the developing phase of spontaneous hypertension (de Jong, Lovenberg & Sjoerdsma, 1972; Sen, Smeby & Bumpus, 1972) and in renal hypertension. Ganten et at. (1975) and Hutchinson et at. (1975) showed that AII, produced by the intrinsic brain isorenin-angiotensin system, is secreted into the cerebrospinal fluid. Its concentration is elevated in the cerebrospinal fluid of spontaneously hypertensive rats. 3H-labelled AII, injected intravenously into rats, does not cross the blood-cerebrospinal fluid barrier as an intact molecule. Central administration of another A11 analogue (Sar',Va15,Alas-AIl) also caused a decrease of systemic blood pressure in spontaneously hypertensive rats less than 3 months old (Hutchinson  et at., 1975; Ganten et at., 1975) . Comparing the effect of the A11 analogue after central and peripheral administration it seems likely that different mechanisms are responsible for the opposite influences on blood pressure in spontaneous hypertension in 10-weeks-old animals and in renal hypertension.
From these results it can be assumed that the intrinsic brain isorenin-angiotensin system seems to be involved in central blood pressure regulation in experimental hypertension. 
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